Ependymoma (controls excluding all cancers)

C3_EPENDYDOMA_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cancer registry: Topography ICD-O-3 ANY
Cancer registry: Morphology ICD-O-3 939[1-3]
Cancer registry: Behaviour codes 3

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

39

diagram downward connector
C3_EPENDYDOMA_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy C
First used in FinnGen datafreeze DF9

Summary Statistics

Key figures

All Female Male
Number of individuals 39 21 18
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 42.46 46.74 37.47

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: C3_EPENDYDOMA_EXALLC – Ependymoma (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Ependymoma (controls excluding all cancers)

Endpoint not on priority list, no data to show.